Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 7/20 | 0.36 |
| ▸ | GRIN3B | O60391 | 7/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 7/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 7/20 | 0.36 |
| ▸ | GRIN2B | Q13224 | 7/20 | 0.36 |
| ▸ | GRIN2C | Q14957 | 7/20 | 0.36 |
| ▸ | GRIN3A | Q8TCU5 | 7/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | STAT6 | P42226 | 1/20 | 0.35 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2832554 | 0.97 | GRIN2D (0.35) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL2929939 | 0.94 | GRIN2D (0.36) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL6105432 | 0.92 | GRIN2D (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL128692 | 0.85 | EPHX2 (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL19588665 | 0.85 | EPHX2 (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL20067101 | 0.85 | EPHX2 (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL20077560 | 0.85 | EPHX2 (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL27367847 | 0.85 | EPHX2 (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30985685 | 0.84 | EPHX2 (0.37) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Iodide SCHEMBL237045 | 0.84 | EPHX2 (0.37) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2243549-B1 | A CATALYST SYSTEM | LUCITE INT UK LTD (GB) | 2020-09-02 | — | — | EP | disclosed |
| US-9802185-B2 | Catalyst system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2017-10-31 | — | — | US | disclosed |
| US-20150321186-A1 | CATALYST SYSTEM | Mitsubishi Chemical UK Limited (GB) | 2015-11-12 | — | — | US | disclosed |
| EP-2243548-B1 | A CATALYST SYSTEM | LUCITE INT UK LTD (GB) | 2015-11-11 | — | — | EP | disclosed |
| US-9040445-B2 | Catalyst system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2015-05-26 | — | — | US | disclosed |
| EP-1713582-B1 | A CATALYST SYSTEM | LUCITE INT UK LTD (GB) | 2013-11-06 | — | — | EP | disclosed |
| EP-2243549-A1 | A catalyst system | Lucite International UK Limited (GB) | 2010-10-27 | — | — | EP | disclosed |
| EP-2243548-A1 | A catalyst system | Lucite International UK Limited (GB) | 2010-10-27 | — | — | EP | disclosed |
| EP-1534427-B1 | AN ADAMANTYL CATALYST SYSTEM | LUCITE INT UK LTD (GB) | 2009-10-21 | — | — | EP | disclosed |
| US-7371705-B2 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-05-13 | — | — | US | disclosed |
| US-7371705-B2 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-05-13 | — | — | US | disclosed |
| US-7371705-B2 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2008-05-13 | — | — | US | disclosed |
| US-20070282124-A1 | Catalyst System | LUCENT INTERNATIONAL UK LIMITED (GB) | 2007-12-06 | — | — | US | disclosed |
| EP-1713582-A1 | A CATALYST SYSTEM | Lucite International UK Limited (GB) | 2006-10-25 | — | — | EP | disclosed |
| US-20060106259-A1 | Phospha-adamantane(s) catalytic system | LUCITE INTERNATIONAL UK LIMITED (GB) | 2006-05-18 | — | — | US | disclosed |
| WO-2005079981-A1 | A CATALYST SYSTEM | LUCITE INTERNATIONAL UK LIMITED (GB) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106259-A1 | Phospha-adamantane(s) catalytic system | ADORA2A, ADORA3, ADGRE5 | GRIN2D 567/4885GRIN3B 522/4885GRIN1 1249/4885 |
| US-20150321186-A1 | CATALYST SYSTEM | SMS, COASY, ABCB7 | GRIN2D 3265/4885GRIN3B 1989/4885GRIN1 2911/4885 |
| US-20070282124-A1 | Catalyst System | SMS, COASY, ABCB7 | GRIN2D 3265/4885GRIN3B 1989/4885GRIN1 2911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.